Clinical Trial Update: GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating a GLP-1/GCG dual agonist in people with Type 2 diabetes and early dementia or mild cognitive impairment is currently recruiting. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1/GCG dual agonist (GLP-1/GCG dual agonist)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Dementia, Mild, Mild Cognitive Impairment | Phase 3 | Status: RECRUITING